According the report, Oncolytic Virus are used as new Therapeutic Agents in the Field of Malignant Tumor Treatment is one of the primary growth factors for the market. Increasing chronic diseases such as cancer, diabetes, epilepsy are the major driver of the global oncolytic virus market. In recent years, the global rate of cancer incidence has increased. Cancer is still a significant factor in threatening human health. Cancer cells use high mutation to evade immune surveillance, gradually forming a low pH, low oxygen microenvironment containing proteolytic enzymes. is also expected to contribute significantly to the Oncolytic Virus market. Overall, Breast Cancer applications of Oncolytic Virus, and the growing awareness of them, is what makes this segment of the industry important to its overall growth.

AMA’s Analyst on the Global Oncolytic Virus market identified that the demand is rising in many different parts of the world as "Rising Healthcare Spending in Developed and Developing Economies ". Furthermore, some recent industry insights like "In November 2021 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), announced that it has launched DELYTACT® (teserpaturev/G47∆)*1, an oncolytic virus developed by the, company in collaboration with Professor Tomoki Todo (hereinafter, Dr. Todo) of the Institute of Medical and Science, The University of Tokyo." is constantly making the industry dynamic. One of the challenges that industry facing is "Choice of virus platform."

The End User, such as Hospitals, is boosting the Oncolytic Virus market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Oncolytic Virus market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Oncolytic Virus market and other related sub-markets covered in the study.

o Key & emerging players in the Oncolytic Virus market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation
The overall Oncolytic Virus market size is calculated using market estimation process, the Oncolytic Virus market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Oncolytic Virus market size has been validated using both top-down and bottom-up approaches.